Scopus h-index:8
- Home
- Profiles
Video Visit Available
Accepting New Patients
Mount Sinai Doctors
Video Visit Available
Accepting New PatientsAdam Morgenthau, MD
Pulmonary Medicine (Lung)
Mount Sinai-National Jewish Respiratory Institute
212-241-5656
- About Me
- Clinical Focus
- Education & Certifications
- Research
- Locations
- Insurance
- Publications
- Patient Experience Rating
- Industry Relationships
About Me
During his Fellowship at Johns Hopkins, Dr. Morgenthau developed clinical and research interests in sarcoidosis. Dr. Morgenthau is currently the Director of the Sarcoidosis Clinic and the Alvin S. Teirstein Sarcoidosis Support Group at the Mount Sinai Hospital. Dr. Morgenthau has published extensively on sarcoidosis. He is currently a co-investigator on a clinical trial examining new treatments in sarcoidosis.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
About Me
During his Fellowship at Johns Hopkins, Dr. Morgenthau developed clinical and research interests in sarcoidosis. Dr. Morgenthau is currently the Director of the Sarcoidosis Clinic and the Alvin S. Teirstein Sarcoidosis Support Group at the Mount Sinai Hospital. Dr. Morgenthau has published extensively on sarcoidosis. He is currently a co-investigator on a clinical trial examining new treatments in sarcoidosis.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
About Me
During his Fellowship at Johns Hopkins, Dr. Morgenthau developed clinical and research interests in sarcoidosis. Dr. Morgenthau is currently the Director of the Sarcoidosis Clinic and the Alvin S. Teirstein Sarcoidosis Support Group at the Mount Sinai Hospital. Dr. Morgenthau has published extensively on sarcoidosis. He is currently a co-investigator on a clinical trial examining new treatments in sarcoidosis.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
Clinical Focus
Education
MD, Sackler School of Medicine
Internship, Internal Medicine
North Shore-Long Island Jewish Health System
Residency, Pulmonary & Critical Care
North Shore-Long Island Jewish Health System
Fellowship, Pulmonary & Critical Care
Johns Hopkins Hospital
Certifications
Pulmonary Disease
Research
Dr. Morgenthau is the Director of the Sarcoidosis Program.
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- Mount Sinai-National Jewish Respiratory Institute10 East 102nd Street, 5th Floor, New York, NY, 10029
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- AgeWell New York
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Hotel Trades
- Magnacare-Health Care
- Medicare
- Metroplus
- Multiplan PHCS
- NY Medicaid
- Oxford - Freedom & Liberty
- Partners Health Plan
- Select Health Medicaid - VNSNY
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Article:7
Review Article:5
Editorial:1
Recent Artifacts
- Artificial Intelligence for Interstitial Lung Disease Analysis on Chest Computed Tomography: A Systematic Review
- Pulmonary Artery <sup>18</sup>F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis
- Utility of electrophysiologic testing for sudden death risk stratification in cardiac sarcoidosis patients with mildly impaired left ventricular function
- Moderate or Severe Impairment in Pulmonary Function is Associated with Mortality in Sarcoidosis Patients Infected with SARS‑CoV‑2
- Diagnosis and Detection of Sarcoidosis An Official American Thoracic Society Clinical Practice Guideline
- Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): Genuine disease entity, obscure clinical phenotype or diagnostic red herring?
- The WASOG sarcoidosis organ assessment instrument: An update of a previous clinical tool
- Catheter ablation of atrial arrhythmias in cardiac sarcoidosis
- Sarcoidosis of the upper and lower airways
- Recent advances in sarcoidosis
Patient Experience Rating
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai physician communicated with them during an office visit. The Star Rating is based on patient responses to three questions on the Clinician & Group CAHPS (CG-CAHPS) Survey, a standardized questionnaire developed by Medicare. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Explains in a way you understand
4.9 out of 5
Listens carefully
4.9 out of 5
Likelihood to recommend
4.8 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Morgenthau did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.